Third time’s the charm: Dynavax shares rocket 18% on hepatitis B vaccine approval By: MarketWatch November 10, 2017 at 08:47 AM EST The vaccine is then first new hepatitis B one in the U.S. in decades and should be a lot more convenient to get. Read More >> Related Stocks: Dynavax Technologies Standard & Poors 500